These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 14623174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: particular potency of 1H-indazole-7-carbonitrile.
    Cottyn B, Acher F, Ramassamy B, Alvey L, Lepoivre M, Frapart Y, Stuehr D, Mansuy D, Boucher JL, Vichard D.
    Bioorg Med Chem; 2008 Jun 01; 16(11):5962-73. PubMed ID: 18502134
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I.
    Mol Pharmacol; 2000 Nov 01; 58(5):1026-34. PubMed ID: 11040050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alternative nitric oxide-producing substrates for NO synthases.
    Mansuy D, Boucher JL.
    Free Radic Biol Med; 2004 Oct 15; 37(8):1105-21. PubMed ID: 15451052
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug.
    Ask K, Dijols S, Giroud C, Casse L, Frapart YM, Sari MA, Kim KS, Stuehr DJ, Mansuy D, Camus P, Boucher JL.
    Chem Res Toxicol; 2003 Dec 15; 16(12):1547-54. PubMed ID: 14680368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL, Moore PK.
    Br J Pharmacol; 1998 Mar 15; 123(6):1119-26. PubMed ID: 9559895
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of nitric-oxide synthase by nicotine.
    Tonnessen BH, Severson SR, Hurt RD, Miller VM.
    J Pharmacol Exp Ther; 2000 Nov 15; 295(2):601-6. PubMed ID: 11046094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
    Babu BR, Griffith OW.
    J Biol Chem; 1998 Apr 10; 273(15):8882-9. PubMed ID: 9535869
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
    Ichimori K, Stuehr DJ, Atkinson RN, King SB.
    J Med Chem; 1999 May 20; 42(10):1842-8. PubMed ID: 10346937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.